Enzymatic properties and anticancer activity of L-lysine α-oxidase from Trichoderma cf. aureoviride Rifai BKMF-4268D

Anti-Cancer Drugs

Volumn 24, Issue 8, 2013, Pages 846-851

  Pokrovsky, Vadim S ^a   Treshalina, Helen M ^a   Lukasheva, Elena V ^b   Sedakova, Ludmila A ^a   Medentzev, Alexander G ^c   Arinbasarova, Anna Yu ^c   Berezov, Temirbolat T ^b  

^a D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^b PEOPLES FRIENDSHIP UNIVERSITY OF RUSSIA   (Russian Federation)

^c SKRYABIN INSTITUTE OF BIOCHEMISTRY AND PHYSIOLOGY OF MICROORGANISMS   (Russian Federation)

Author keywords

anticancer activity; L lysine a oxidase; Trichoderma cf. aureoviride Rifai

Indexed keywords

ARGININE; DIMER; LYSINE OXIDASE; ORNITHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CELL STRAIN MCF 7; CELL VIABILITY; COLON CANCER; COLON CARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME SPECIFICITY; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HYPHOMYCETES; IC 50; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN STABILITY; THERMOSTABILITY; TRICHODERMA; TRICHODERMA AUREOVIRIDE; TUMOR CELL LINE; TUMOR XENOGRAFT;

AMINO ACID OXIDOREDUCTASES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME STABILITY; FEMALE; FUNGAL PROTEINS; HT29 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; INHIBITORY CONCENTRATION 50; K562 CELLS; KINETICS; LYSINE; MALE; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR WEIGHT; NEOPLASMS; PROTEIN MULTIMERIZATION; SUBSTRATE SPECIFICITY; TIME FACTORS; TRICHODERMA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84881071242     PISSN: 09594973     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328362fbe2     Document Type: Article

References (20)

1. Cappelletti D, Chiarelli LR, Pasquetto MV, Stivala S, Valentini G, Scotti C. Helicobacter pylori L-asparaginase: a promising chemotherapeutic agent. Biochem Biophys Res Commun 2008; 377:1222-1226.
2. Shrivastava A, Khan AA, Jain SK, Singhal PK, Jain S, Marotta F, et al. Biotechnological advancement in isolation of anti-neoplastic compounds from natural origin: a novel source of L-asparaginase. Acta Biomed 2010; 81:104-108.
3. Oza VP, Parmar PP, Kumar S, Subramanian RB. Anticancer properties of highly purified L-asparaginase from Withania somnifera L. against acute lymphoblastic leukemia. Appl Biochem Biotechnol 2010; 160:1833-1840.
4. Van den Berg H. Asparaginase revisited. Leuk Lymphoma 2011; 52:168-178.
5. Porta C, Paglino C, Mutti L. Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma. Biologics 2008; 2:601-609.
6. Yang TS, Lu SN, Chao Y, Sheen IS, Lin CC, Wang TE, et al. A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients. Br J Cancer 2010; 103:954-960.
7. Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A, et al. Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J Clin Oncol 2005; 23:7660-7668.
8. Kusakabe P, Kodama K, Kuninaka A, Yoshino H, Misono H, Soda K. A new antitumor enzyme, L-lysine-alpha-oxidase from Trichoderma viride. J Biol Chem 1980; 255:976-981.
9. Lukasheva EV, Berezov TT. L-Lysine alpha-oxidase: physicochemical and biological properties. Biochemistry (Mosc) 2002; 67:1152-1158.
10. Treshalina HM, Lukasheva EV, Sedakova LA, Firsova GA, Guerassimova GK, Gogichaeva GK, et al. Anticancer enzyme L-lysine a-oxidase. Properties and application perspectives. Appl Biochem Biotechnol 2000; 84:267-273.
11. Kusakabe H, Kodama K, Kuninaka A, Yoshino H, Soda K. Effect of L-lysine a-oxidase on growth of mouse leukemic cells. Agric Biol Chem 1980; 44:387-392.
12. Lukasheva EV, Efremova AA, Treshalina EM, AYu Arinbasarova, Medentzev AG, Berezov TT. L-Amino acid oxidases: properties and molecular mechanisms of action. Biochemistry (Mosc) 2011; 5:337-345.
13. Teicher BA, Andrews PA. Anticancer drugs development guide. 2nd ed. Totowa, NJ: Humana Press; 2004; p. 450.
14. Pokrovskaya MV, Aleksandrova SS, Pokrovsky VS, Omeljanjuk NM, Borisova AA, Anisimova NYu, et al. Cloning, expression and characterization of the recombinant Yersinia pseudotuberculosis L-asparaginase. Protein Expr Purif 2012; 82:150-154.
15. Kozai M, Sasamori E, Fujihara M, Yamashita T, Taira H, Harasawa R. Growth inhibition of human melanoma cells by a recombinant arginine deiminase expressed in Escherichia coli. J Vet Med Sci 2009; 71:1343-1347.
16. Schulenburg C, Ardelt B, Ardelt W, Arnold U, Shogen K, Ulbrich-Hofmann R, et al. The interdependence between catalytic activity, conformational stability, and cytotoxicity of onconase. Cancer Biol Ther 2007; 6:1233-1239.
17. Pokrovskaya MV, Pokrovsky VS, Aleksandrova SS, NYu Anisimova, Andrianov RM, Treschalina EM, et al. Recombinant intracellular Rhodospirillum rubrum L-asparaginase with low L-glutaminase activity and antiproliferative effect. Biochemistry (Mosc) 2012; 6:125-133.
18. Sabatino MA, Colombo T, Geroni C, Marchini S, Broggini M. Enhancement of in vivo antitumor activity of classical anticancer agents by combination with the new, glutathione-interacting DNA minor groove-binder, brostallicin. Clin Cancer Res 2003; 9:5402-5408.
19. Lukasheva EV, Lukashev AN, Pokrovsky VS, Treshhalina EM, Shumilina EJu, Arinbasarova AJu, et al. Study of pharmacokinetic properties of L-lysine-a-oxidase [in Russian]. Vopr Med Biol Pharm Chem 2013; 1:57-62.
20. Kusakabe H, Kodama K, Machida H, Midorikawa Y, Kuninaka A, Misono H, et al. Occurrence of a novel enzyme, L-lysine oxidase with antitumor activity in culture extract of Trichoderma viride. Agric Biol Chem 1979; 43:337-343.